Top Markets
Coin of the day
Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd.

TARO
Κατάταξη σε μετοχές #7354
Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven... Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven pharmaceutical enterprise, specializing in the development, manufacturing, and commercialization of both prescription and over-the-counter medications. Its market reach spans the United States, Canada, Israel, and various other international territories. The company also produces active pharmaceutical ingredients (APIs), primarily for integration into its own finished dosage form products. Its extensive product catalog addresses a broad spectrum of medical conditions and therapeutic areas, encompassing treatments for allergies, pain (analgesic), bacterial and fungal infections (antibacterial, antibiotic, antifungal), seizures (anticonvulsant), nausea (antiemetic), inflammation (anti-inflammatory), cancer (anti-cancer, topical anti-neoplastic), blood clot prevention (antiplatelet agent), fever reduction (antipyretic), cardiovascular issues, central nervous system disorders, hormonal regulation (corticosteroid, endocrine), cosmetic applications, coughs and colds, dermatological complaints, fluid management (diuretic), gastrointestinal problems, constipation (laxative), severe pain (narcotics), neuropathic pain, neuropsychiatric conditions, and sleep/anxiety management (sedative/hypnotic). These pharmaceutical goods are available in numerous formats, including capsules, creams, drops, emulsions, gels (and gel kits), granules, injectables, lotions, oils, ointments, pastes, powders (and powders for solution), rectal suppositories, shampoos, solutions (and solutions for infusion), sprays, suspensions, syrups, tablets, toothpastes and mouthwashes, topical foams, and topical solutions. Taro distributes and sells its products directly to a wide array of clients, such as pharmaceutical wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, other direct purchasers, and various healthcare institutions and private pharmacies. The company was established in 1950, with its main offices situated in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a wholly-owned subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.
Τιμή μετοχής
$42.98
Τελευταίος συγχρονισμός: 2024-06-21
Κεφαλαιοποίηση
$1.62B
Αλλαγή (1 ημέρα)
0.01%
Αλλαγή (1 έτος)
0.00%
Χώρα
IL
Εμπόριο Taro Pharmaceutical Industries Ltd. (TARO)

Κατηγορία

Έσοδα για την Taro Pharmaceutical Industries Ltd. (TARO)
Έσοδα τον Mar 2024 TTM: $629.18M
Σύμφωνα με τις τελευταίες οικονομικές αναφορές της Taro Pharmaceutical Industries Ltd., τα τρέχοντα έσοδα της εταιρείας (TTM) είναι $629.18M. Το 2023, η εταιρεία είχε έσοδα $572.95M αύξηση σε σχέση με τα έσοδα του έτους 2022, τα οποία ήταν $561.35M. Τα έσοδα είναι το συνολικό ποσό που παράγει μια εταιρεία από τις πωλήσεις προϊόντων ή υπηρεσιών. Σε αντίθεση με τα κέρδη, δεν αφαιρούνται έξοδα.
Ιστορικό εσόδων για την Taro Pharmaceutical Industries Ltd. από 1999 έως 2026
Έσοδα στο τέλος κάθε έτους
Έτος Έσοδα Αλλαγή
2026 (TTM) $629.18M 0.00%
2024 $629.18M 9.81%
2023 $572.95M 2.07%
2022 $561.35M 2.25%
2021 $548.97M -14.86%
2020 $644.77M -3.75%
2019 $669.89M 1.21%
2018 $661.91M -24.73%
2017 $879.39M -7.51%
2016 $950.75M 10.18%
2015 $862.94M 13.65%
2014 $759.29M 13.16%
2013 $670.95M 23.55%
2012 $543.08M 38.35%
2010 $392.54M 9.76%
2009 $357.64M 8.69%
2008 $329.04M 2.97%
2007 $319.55M 26.67%
2006 $252.27M -15.27%
2005 $297.74M 4.79%
2004 $284.13M -9.93%
2003 $315.46M 49.10%
2002 $211.58M 40.93%
2001 $150.13M 44.64%
2000 $103.80M 23.88%
1999 $83.79M 0.00%
Έσοδα για παρόμοιες εταιρείες ή ανταγωνιστές